MarketsandMarkets Biomarker and Companion Diagnostics Conference-East Coast Edition
22
Jun
-
23
Jun
2023
When
Boston
USA
Where

The Biomarker and Companion Diagnostics Conference, organized by MarketsandMarkets, is set to take place on the 22nd and 23rd of June 2023 in Boston, USA. The event aims to explore how next-generation technologies can be used to advance biomarker drug discovery beyond conventional methods.

The conference will feature presentations by over 30 experts from academia and industry, who will share their current research in the areas of biomarkers, regulatory guidelines, cancer biomarker validation, personalized medicine, big data in translational biomarker research, and the future of companion diagnostics.

Attendees will have the opportunity to develop lasting business relationships and network with professionals from pharmaceutical and bio-pharma companies, universities, research institutes, clinicians, and scientists.

The event will consist of more than 20 presentations, round-tables, and panel discussions, which will focus on the major opportunities and challenges in biomarker research. These discussions will cover various topics, such as precision medicine, companion diagnostics, digital biomarkers, and clinical trials.

Similar Events

You May Like

Event

MarketsandMarkets

0/5
(0)

In the decade of the 2020s, the B2B world will see $25 trillion worth of disruptive revenue shifts. Organizations globally are navigating both the opportunities and risks that are consequent.

22 - 23 Jun 2023
In-Person

Speakers and Delegates
Industry Experts and Thought Leaders

Scientist
President & Chief Scientific Officer
Chief Scientific Officer, Senior Vice President
Executive Vice President and Chief Medical Officer
Executive Director and Head, Precision Medicine Laboratory Operations and Companion
Principal Scientist
Executive Director and Distinguished Scientist, Companion Diagnostics
Vice President of biomarker and CDx services
Principal Scientist, Translational Science

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Danaher Corporation

Danaher is a global science and technology innovator committed to helping our customers solve complex challenges and improve quality of life around the world.

HTG Molecular Diagnostics

HTG is accelerating precision medicine from diagnosis to treatment by harnessing the power of transcriptome-wide profiling to drive translational research, clinical diagnostics and targeted therapeutics across a variety of disease areas.

Burning Rock Biotech

Burning Rock's laboratory has obtained the technical certification of “High-throughput sequencing laboratory” issued by Guangdong Center for Clinical Laboratory, and the CLIA and CAP laboratory quality system certification.

Organizer

Get emails from us

Thank you
Oops! Something went wrong